We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Recently, cyclophosphamide capsules of Hengrui Medicine and human growth hormone recombination injection of GeneScience Pharmaceuticals were proposed to be included in the priority review by CDE...